Guardian Wealth Advisors (North Carolina)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Guardian Wealth Advisors (North Carolina)'s PFE Position: Q2 2026 in Review
Guardian Wealth Advisors (North Carolina) reduced its Pfizer (PFE) stake by 4.1% in Q2 2026, selling an estimated $41.8K and leaving 37,571 shares worth $905K. The position accounts for 0.05% of the portfolio, ranked #168.
Guardian Wealth Advisors (North Carolina) first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.5M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Guardian Wealth Advisors (North Carolina) held 37,571 shares of Pfizer worth $905K as of Q2 2026.
- Guardian Wealth Advisors (North Carolina) sold 1,598 Pfizer shares in Q2 2026, an estimated $41.8K.
- Pfizer made up 0.05% of Guardian Wealth Advisors (North Carolina)'s portfolio in Q2 2026, its #168 holding.
- Guardian Wealth Advisors (North Carolina) first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Guardian Wealth Advisors (North Carolina)'s Pfizer position peaked at $2.5M in Q4 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q2 2026, filed 14 Aug 2026.